Unique Metabolic Signatures Detected in More Than 50% of Children with ASD
The research represents an important step toward the development of a panel of tests that could form the basis for a biological screen of risk for autism.
Read MorePosted by Laurie Bonner | Jul 19, 2020 | Immunoassay |
The research represents an important step toward the development of a panel of tests that could form the basis for a biological screen of risk for autism.
Read MorePosted by Steve Halasey | Feb 26, 2020 | Hematology & Serology, Molecular Diagnostics |
The test can determine whether a patient has a number of CGG repeats that is considered either normal, intermediate, premutation, or full mutation.
Read MorePosted by Chaunie Brusie | Jun 30, 2019 | Software, Standards |
The signature genetics program now boasts the world’s largest whole-genome database focused on developing new solutions for individuals with autism and their families.
Read MorePosted by Chaunie Brusie | Apr 19, 2019 | Research |
The panel helps physicians diagnose neuropsychiatric conditions thought to be triggered by an autoimmune response to common infections.
Read MorePosted by Elaine Sanchez Wilson | Sep 12, 2017 | Molecular Diagnostics |
PerkinElmer has expanded its whole-genome sequencing services to families that preserve their cord blood and cord tissue by using the company’s ViaCord tissue preservation service.
Read More